Illumina Inc
About
Illumina Inc (NASDAQ:ILMN) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 16 2026
DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows
Apr 14 2026
Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease
Apr 9 2026
Illumina to Announce First Quarter 2026 Financial Results on Thursday, April 30, 2026
Apr 2 2026
Illumina Announces Changes to Board of Directors
Mar 18 2026
Illumina and Labcorp expand collaboration to broaden access to precision oncology testing
Financials
Revenue
$4.34 B
Market Cap
$19.48 B
P/E Ratio
23.37
EPS
5.45